{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining issues related to competition in the pharmaceutical marketplace :
a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Examining Issues Related To Competition In The Pharmaceutical Marketplace : A Review Of The FTC Report, Generic Drug Entry Prior To Patent Expiration : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Seventh Congress, Second Session, October 9, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],
2002.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining issues related to competition in the pharmaceutical marketplace :
a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Examining Issues Related To Competition In The Pharmaceutical Marketplace : A Review Of The FTC Report, Generic Drug Entry Prior To Patent Expiration : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Seventh Congress, Second Session, October 9, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],
2002.